Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
01/2010
01/05/2010CA2395601C Dibenzo (b,f) azepine intermediates
01/05/2010CA2383769C Indole derivatives
01/05/2010CA2373757C Treatment of neurotic disorders
01/05/2010CA2322168C Method for treating painful conditions of the anal region and compositions therefor
01/05/2010CA2318192C .beta.2-adrenergic receptor agonists
12/2009
12/31/2009US20090326275 Use of nitrogen-containing curcumin analogs for the treatment of alzheimers disease
12/31/2009US20090326233 4-phenylpiperidine compounds
12/31/2009US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use
12/31/2009US20090326072 USE OF 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-l,3- CYCLOHEXANEDIONE IN THE TREATMENT OF PARKINSON'S DISEASE
12/31/2009US20090326067 Levodopa Prodrug Mesylate, Compositions Thereof, and Uses Thereof
12/31/2009US20090326062 Process for preparing entacapone substantially free of z-isomer, synthesis intermediates thereof and a new crystalline form
12/31/2009US20090326059 Benzyloxy anilide derivatives useful as potassium channel modulators
12/31/2009US20090326038 Method for treating a immunology-related disease
12/31/2009US20090326036 [2-(6-fluoro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
12/31/2009US20090326027 N-Phenyl-2-0X0-1,4-Diazaspiro [4.5] Dec-3-EN-1-YL Acetamide Derivatives And Their Use As Glycine Transporter Inhibitors
12/31/2009US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists
12/31/2009US20090326006 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors
12/31/2009US20090326002 Thieno [2,3-b] Pyridine Compounds with mGluR Activity
12/31/2009US20090326001 Thienopyridine derivatives as modulators of metabotropic glutamate receptors
12/31/2009US20090325993 GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders
12/31/2009US20090325991 Spirolactam Bicyclic CGRP Receptor Antagonists
12/31/2009US20090325988 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof
12/31/2009US20090325987 Quinazolinedione derivatives as trpa1 modulators
12/31/2009US20090325984 Use of 1,7-dimethylxanthine for the manufacture of a non-anxiogenic psychoanaleptic drug for the treatment of a neuropsychiatric disorder
12/31/2009US20090325983 New purine derivatives
12/31/2009US20090325982 Phosphodiesterase 4 inhibitors
12/31/2009US20090325968 Compositions Useful as Inhibitors of Protein Kinases
12/31/2009US20090325962 Tyrosine derivative
12/31/2009US20090325951 Thienyl-and furanyl-isoquinolinones and methods for using them
12/31/2009US20090325950 Benzoxazine derivatives and uses thereof
12/31/2009US20090325943 Veterinary pharmaceutical compositions for the treatment of pain and inflammation
12/31/2009US20090325942 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals
12/31/2009US20090325939 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
12/31/2009US20090325937 Pyridazine Compounds as Glycogen Synthase Kinase 3 Inhibitors
12/31/2009US20090325936 Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
12/31/2009US20090325933 Pyrimidinone Derivatives and Their Use as a Drug
12/31/2009US20090325930 Selective estrogen receptor modulator
12/31/2009US20090325920 Methods for the treatment of a traumatic central nervous system injury
12/31/2009US20090325896 Partial and full agonists of a1 adenosine receptors
12/31/2009US20090325874 Inhibition of inositol 1,4,5-triphosphate receptor calcium channel/cytochrome c interactions and uses thereof
12/31/2009US20090325873 Human glp-1 mimetibodies, compositions, methods and uses
12/31/2009US20090325865 Liquid Formulations of Pegylated Growth Hormone
12/31/2009US20090325289 Process for the multiplication of stem cells
12/31/2009US20090324754 Eucalyptus extract, method of preparation and therapeutic uses thereof
12/31/2009US20090324751 Chinese herb extract for treating dementia and preparation method thereof
12/31/2009US20090324703 Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders
12/31/2009US20090324675 Bioocompatible polymer compositions
12/31/2009US20090324647 Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use
12/31/2009US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
12/31/2009US20090324598 Method for the treatment of inflammatory disorders
12/31/2009US20090324558 Transdiscal administration of cycline compounds
12/31/2009US20090324555 Neural Stem Cells
12/31/2009US20090324542 optic neuritis; fingolimod or 2-amino-2-{2-[4-(1-oxo-5-phenylpentyl)phenyl]ethyl}propane-1,3-diol or salts as SP1 agonist
12/31/2009US20090324492 Treatment for Central Nervous System Disorders
12/31/2009US20090320845 Method of demand valve oxygen therapy for rapid abort of cluster headache
12/31/2009DE102008029460A1 Taxifolinderivate zur Prophylaxe und Behandlung von neurologischen und psychiatrischen Störungen des zentralen Nervensystems Taxifolinderivate for the prophylaxis and treatment of neurological and psychiatric disorders of the central nervous system
12/30/2009WO2009158473A1 5- and 6-membered heterocyclic compounds
12/30/2009WO2009158467A2 Di-substituted phenyl compounds
12/30/2009WO2009158447A2 Materials and methods for suppressing and/or treating neurofibroma and related tumors
12/30/2009WO2009158446A2 Crystalline forms of ((((4-((5-(cyclopropylcarbamoyl)-2-methylphenyl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbonyl)(propyl)carbamoyl)oxy)methyl (4-(phosphonooxy)phenyl)acetate, method of preparation and use thereof
12/30/2009WO2009158393A1 1, 2 disubstituted heterocyclic compounds
12/30/2009WO2009158387A2 Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
12/30/2009WO2009157858A1 Use of cyclolignans for the treatment of a hyperactive immune system
12/30/2009WO2009157586A1 Transdermal patch containing fentanyl or salt thereof
12/30/2009WO2009157562A1 Method for establishment of adult pancreatic stem cell, and method for differentiation of adult pancreatic stem cell
12/30/2009WO2009157515A1 Pharmaceutical compositions
12/30/2009WO2009157418A1 Carboxylic acid compound
12/30/2009WO2009157396A1 Therapeutic agent for spinal canal stenosis
12/30/2009WO2009157196A1 Amide compound
12/30/2009WO2009157083A1 Method of bioassaying yokkansan
12/30/2009WO2009156991A2 Glycerophospholipids for the improvement of cognitive functions
12/30/2009WO2009156951A2 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
12/30/2009WO2009156889A1 Diaryl compounds and uses thereof
12/30/2009WO2009156865A1 Substituted pyrimidin-4-one derivatives
12/30/2009WO2009156864A2 Substituted alkyl pyrimidin-4-one derivatives
12/30/2009WO2009156863A2 Substituted tricyclic derivatives
12/30/2009WO2009156861A2 Substituted pyrimidone derivatives
12/30/2009WO2009156860A2 Substituted triazinone derivatives
12/30/2009WO2009156859A1 Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives
12/30/2009WO2009156857A1 Substituted n-oxide pyrazine derivatives
12/30/2009WO2009156737A1 Triazolo [4, 5-d] pyramidine derivatives and their use as purine receptor antagonists
12/30/2009WO2009156680A2 Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders
12/30/2009WO2009156678A2 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
12/30/2009WO2009156544A1 Complexes of albumin with omega-9 monounsaturated fatty acids for treatment of medullary lesions
12/30/2009WO2009156535A1 Hydrazides of heterocyclic systems and use thereof in the treatment of neurodegenerative diseases
12/30/2009WO2009156479A1 Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
12/30/2009WO2009156466A1 Pharmaceutical compositions for the treatment of neurodegenerative diseases
12/30/2009WO2009156458A1 Novel phenolic and catecholic amines and prodrugs thereof
12/30/2009WO2009156396A1 Novel tetramethyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/30/2009WO2009156380A1 Eltoprazine for suppression of l-dopa induced dyskinesias
12/30/2009WO2009156339A1 Isoquinolinone derivatives as nk3 antagonists
12/30/2009WO2009156161A1 Pharmaceutical compositions comprising aminoadamantane derivatives
12/30/2009WO2009156100A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
12/30/2009WO2009156092A2 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
12/30/2009WO2009155962A1 Use
12/30/2009WO2009155932A2 Modulation of the trpv : vps10p-domain receptor system for the treatment of pain
12/30/2009WO2009155786A1 Amine compounds and their pharmaceutical use
12/30/2009WO2009155777A1 The use and method of the compound of fasudil and the pharmaceutical composition thereof
12/30/2009WO2009155757A1 A pharmaceutical composition containing oligosaccharide obtained from morinda root and the procedure thereof
12/30/2009WO2009133141A3 New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of angiogenesis
1 ... 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 ... 1833